Viewing Study NCT06380218


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
Study NCT ID: NCT06380218
Status: RECRUITING
Last Update Posted: 2024-04-23
First Post: 2024-03-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)
Sponsor: Institut Pasteur de Lille
Organization:

Study Overview

Official Title: Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SAFE
Brief Summary: The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women at risk of cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.
Detailed Description: The objective is to evaluate the effect of a nutritional prevention program associated with the consumption of "Primevère margarine" on the quality of life of women aged 40 to 65 with cardiovascular risk 3 months after 10 group coaching sessions.

The nutritional prevention program includes tools and 10 collective workshops to change the life behaviours (eating habits and physical activity) by assessing :

* Food balance and diversity
* Eating behaviour and representations
* Level of knowledge in nutrition
* Level of physical activity and physical inactivity
* Physical abilities: strength, balance, flexibility, cardio respiratory endurance, recovery capacity
* Behavioural barriers and educational levers to improve women's cardiovascular health

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: